摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(trichloroacetamido)phenyl 2-deoxy-4,6-di-O-acetyl-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-1-thio-2-trichloroacetamido-β-D-galactopyranoside | 500213-06-9

中文名称
——
中文别名
——
英文名称
4-(trichloroacetamido)phenyl 2-deoxy-4,6-di-O-acetyl-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-1-thio-2-trichloroacetamido-β-D-galactopyranoside
英文别名
4-trichloroacetamidophenyl 4,6-di-O-acetyl-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-1-thio-2-trichloroacetamido-β-D-galactopyranoside
4-(trichloroacetamido)phenyl 2-deoxy-4,6-di-O-acetyl-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-1-thio-2-trichloroacetamido-β-D-galactopyranoside化学式
CAS
500213-06-9
化学式
C34H38Cl6N2O17S
mdl
——
分子量
991.463
InChiKey
BWTRPBRWPREEJH-GCISUABHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.63
  • 重原子数:
    60.0
  • 可旋转键数:
    14.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    243.69
  • 氢给体数:
    2.0
  • 氢受体数:
    18.0

反应信息

  • 作为反应物:
    描述:
    4-(trichloroacetamido)phenyl 2-deoxy-4,6-di-O-acetyl-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-1-thio-2-trichloroacetamido-β-D-galactopyranosidesodium methylate 作用下, 以 甲醇 为溶剂, 反应 0.33h, 生成 2,2,2-Trichloro-N-[(2S,3R,4R,5R,6R)-5-hydroxy-6-hydroxymethyl-2-[4-(2,2,2-trichloro-acetylamino)-phenylsulfanyl]-4-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-3-yl]-acetamide
    参考文献:
    名称:
    Synthesis of aminoethyl glycoside of the oligosaccharide chain of ganglioside Fuc-GM1
    摘要:
    通过[3+3]合成方案合成了神经节苷脂 Fuc-GM1 六糖链的 2-氨基乙基糖苷。在合成路线的关键步骤、在合成路线的关键步骤中,将α-(N-乙酰神经氨酸基)-(2→3)-β-D-吡喃半乳糖基-(1→4)-β-D-吡喃葡萄糖苷衍生物中半乳糖残基 C(4)处的唯一羟基与α-L-吡喃葡萄糖基-(1→4)-β-D-吡喃葡萄糖苷的过乙酰化硫代糖苷进行糖基化。L-吡喃葡萄糖基-(1→2)-β-D-吡喃半乳糖基-(1→3)-2-三氯乙酰氨基-2-脱氧-β-D-吡喃半乳糖的过乙酰化硫代糖苷衍生物,高产率地得到了受保护的六糖。随后去除保护基团,就得到了甘神经胶质苷 Fuc-GM1 寡糖链的目标 2-氨基乙基糖苷。
    DOI:
    10.1007/s11172-006-0229-8
  • 作为产物:
    参考文献:
    名称:
    [与二糖β-D-Gal-(1-> 3)-D-GalNAc主链的α-和β-糖基供体的合成]。
    摘要:
    使用一系列适当保护的苯基2的3-单羟基和3,4-二羟基衍生物系列进行糖基化研究了具有二糖β-D-Gal-(1→3)-D-GalNAc主链的硫糖基供体的合成-半乳糖基溴化物,氟化物和三氯乙酰亚氨酸盐形成-叠氮基-2-脱氧-1-硫基-硫代α-和1-硫基-β-D-吡喃半乳糖苷。在与单羟基化的糖基受体的反应中,硫代苯基从糖基受体的分子间转移到由糖基供体分子形成的阳离子上的过程占主导。在相同条件下将3,4-二醇糖基化时,形成的硫代苯基转移产物占主导地位或形成了不希望的(1→4)而非(1→3)连接的二糖产物。当用4-硝基苯硫基取代半乳糖基受体分子中的苯硫基时,糖苷配基转移被排除在外。这产生了目标二糖,4-硝基苯基2-叠氮基-4,5-O-亚苄基-2-脱氧-3-O-(2,3,4,6-四-O-乙酰基-β-D-吡喃半乳糖基)-1-硫代-β-D-吡喃半乳糖苷,产率为57%。该二糖产物在半乳糖胺的2位带有非参与叠
    DOI:
    10.1023/a:1020428329743
点击查看最新优质反应信息

文献信息

  • ——
    作者:P. E. Cheshev、E. A. Khatuntseva、A. G. Gerbst、Yu. E. Tsvetkov、A. S. Shashkov、N. E. Nifantiev
    DOI:10.1023/a:1024905419008
    日期:——
    selectively protected derivatives of tetrasaccharide GalNAc(beta 1-->3)Gal(alpha 1-->4)Gal(beta 1-->4)Glc beta-OCH2CH2N3 and pentasaccharide Gal(beta 1-->3)GalNAc(beta 1-->3)Gal(alpha 1-->4)Gal(beta 1-->4)Glc beta-OCH2CH2N3 in 88 and 73% yields, respectively. Removal of O-protecting groups, substitution of acetyl group for N-trichloroacetyl group, and reduction of the aglycone azide group resulted in the
    6-三-O-乙酰基-2-脱氧-1-代-2-三乙酰基-β-D-喃半乳糖苷和4-三乙酰胺基苯基4,6-二-O-乙酰基-2-脱氧-3-O-(2,在N-代琥珀酰亚胺三氟甲磺酸存在下,二氯甲烷中的3,4,6-四-O-乙酰基-β-D-喃半乳糖基)-1--2-三乙酰胺基-β-D-喃半乳糖苷导致相应的选择性保护四糖GalNAc(β1-> 3)Gal(α1-> 4)Gal(β1-> 4)Glcβ-OCH2CH2N3的衍生物和五糖Gal(β1-> 3)GalNAc(β1- -> 3)Gal(alpha 1-> 4)Gal(beta 1-> 4)Glc beta-OCH2CH2N3,产率分别为88%和73%。除去O-保护基,将乙酰基替换为N-三乙酰基,以及将糖苷配基叠氮基还原,得到目标2-基乙基球蛋白三-,-四-和-五糖,
  • Synthesis of Aminoethyl Glycosides of the Ganglioside GM<sub>1</sub>and Asialo-GM<sub>1</sub>Oligosaccharide Chains
    作者:P. E. Cheshev、E. A. Khatuntseva、Yu. E. Tsvetkov、A. S. Shashkov、N. E. Nifantiev
    DOI:10.1023/b:rubi.0000015775.24385.a0
    日期:2004.1
    4'-O-Glycosylation of 2-azidoethyl 2,3,6-tri-O-benzyl-4-O-(2,3-di-O-benzyl-6-O-benzoyl-beta-D-galactopyranosyl)-beta-D-glucopyranoside with a disaccharide donor, 4-trichloroacetamidophenyl 4,6-di-O-acetyl-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl)-1-thio-2-trichloroacetamido-beta-D-galactopyranoside, in dichloromethane in the presence of N-iodosuccinimide and trifluoromethanesulfonic acid resulted in a tetrasaccharide, 2-azidoethyl (2,3,4,6-tetra-O-acetyl-beta-D-(galactopyranosyl)-(1 --> 3)-(4,6-di-O-acetyl-2-deoxy-2-trichloroacetamido-beta-D-galactopyranosyl)-(1 --> 4)-(2,3-di-O-benzyl-6-O-benzoyl-beta-D-galactopyranosyl)-(1 --> 4)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside, in 69% yield. The complete removal of O-protecting groups in the tetrasaccharide, the replacement of N-trichloroacetyl by N-acetyl group, and the reduction of the aglycone azide group to amine led to the target aminoethyl glycoside of beta-D-Gal-(1 --> 3)-beta-D-Gal-NAc-(1 --> 4)-beta-D-Gal-(1 --> 4)-beta-D-Glc-OCH2CH2NH2 containing the oligosaccharide chain of asialo-GM(1) ganglioside in 72% overall yield. Selective 3'-O-glycosylation of 2-azidoethyl 2,3,6-tri-O-benzyl-4-O-(2,6-di-O-benzyl-beta-D-galactopyranosyl)-beta-D-glucopyranoside with thioglycoside methyl (ethyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-D-glycero-alpha-D-galacto-2-nonulopyranosyl)oate in acetonitrile in the presence of N-iodosuccinimide and trifluoromethanesulfonic acid afforded 2-azidoethyl [methyl (5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosyl)oate]-(2 --> 3)-2,6-di-O-benzyl-beta-D-galactopyranosyl)-(1 --> 4)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside, the selectively protected derivative of the oligosaccharide chain of GM(3) ganglioside, in 79% yield. Its 4'-O-glycosylation with a disaccharide glycosyl donor, (4-trichloroacetophenyl-4,6-di-O-acetyl-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl) 1-thio-2-trichloroacetamido-beta-D-galactopyranoside in dichloromethane in the presence of N-iodosuccinimide and trifluoromethanesulfonic acid gave 2-azidoethyl (2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl)-(1 --> 3)-4,6-di-O-acetyl-2-deoxy-2-trichloroacetamido-beta-D-galactopyranosyl)-(1 --> 4)-[methyl (5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosyl)onate]-(2 --> 3)}-(2,6-di-O-benzyl-beta-D-galactopyranosyl)-(1 --> 4)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside in 85% yield. The resulting pentasaccharide was O-deprotected, its N-trichloroacetyl group was replaced by N-acetyl group, and the aglycone azide group was reduced to afford in 85% overall yield aminoethyl glycoside of beta-D-Gal-(1 --> 3)-beta-D-GalNAc-(1 --> 4)-[alpha-D-Neu5Ac-(2 --> 3)]-beta-D-Gal-(1 --> 4)-beta-D-Glc-OCH2CH2NH2 containing the oligosaccharide chain of GM(1) ganglioside.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸